Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Filings indexed 1,018 across all filing types
Latest filing 2017-06-22 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2017-06-22 English
PRIMARY DOCUMENT
Director's Dealing
2017-06-22 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 21, 2017, by OraSure Technologies, Inc. The key content is the announcement of the appointment of a new director, Mara G. Aspinall, to the company's Board of Directors, including details about her term, committee assignments, and compensation. There is no financial data or report content; the document is focused on management/board changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is under 5,000 characters and includes a press release as an exhibit, but the main content is the management change announcement, not a report publication or regulatory filing. Therefore, the correct classification is MANG with high confidence.
2017-06-22 English
PRIMARY DOCUMENT
Director's Dealing
2017-06-03 English
PRIMARY DOCUMENT
Director's Dealing
2017-05-30 English
PRIMARY DOCUMENT
Director's Dealing
2017-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.